W. Poller

发表

Ubiquitin-Like Protein ISG15 (Interferon-Stimulated Gene of 15 kDa) in Host Defense Against Heart Failure in a Mouse Model of Virus-Induced Cardiomyopathy

K. Knobeloch, K. Klingel, C. Tschöpe, 2014, Circulation.

Immune system-mediated atherosclerosis caused by deficiency of long non-coding RNA MALAT1 in ApoE−/−mice

S. Blankenberg, U. Landmesser, T. Zeller, 2018, Cardiovascular research.

Eosinophilic granulomatosis with polyangiitis (EGPA) with low activity EBV replication during the COVID 19 pandemic

K. Klingel, U. Landmesser, W. Poller, 2022, IJC Heart & Vasculature.

Carvedilol improves left ventricular function in murine coxsackievirus‐induced acute myocarditis Association with reduced myocardial interleukin‐1β and MMP‐8 expression and a modulated immune response

H. Zeichhardt, D. Westermann, H. Schultheiss, 2005, European journal of heart failure.

Reduced Degradation of the Chemokine MCP-3 by Matrix Metalloproteinase-2 Exacerbates Myocardial Inflammation in Experimental Viral Cardiomyopathy

U. Völker, K. Klingel, C. Tschöpe, 2011, Circulation.

The forkhead transcription factor Foxo3 negatively regulates natural killer cell function and viral clearance in myocarditis

S. Blankenberg, S. Heymans, C. Scheibenbogen, 2018, European heart journal.

Interferon- (cid:1) Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction

H. Schultheiss, P. Schwimmbeck, W. Poller, 2003 .

From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases.

T. Lüscher, P. Most, U. Landmesser, 2020, European heart journal.

Role of Left Ventricular Stiffness in Heart Failure With Normal Ejection Fraction

Wolfgang Hoffmann, Dirk Westermann, Paul Steendijk, 2008, Circulation.

Left ventricular dysfunction induced by nonsevere idiopathic pulmonary arterial hypertension: a pressure-volume relationship study.

P. Steendijk, C. Tschöpe, D. Westermann, 2012, American journal of respiratory and critical care medicine.

Response to Letter Regarding Article, “Role of Left Ventricular Stiffness in Heart Failure With Normal Ejection Fraction”

W. Hoffmann, P. Steendijk, C. Tschöpe, 2009 .

Presence of perforin in endomyocardial biopsies of patients with inflammatory cardiomyopathy predicts poor outcome

C. Tschöpe, C. Skurk, D. Westermann, 2014, European journal of heart failure.

Transactivation of human parvovirus B19 gene expression in endothelial cells by adenoviral helper functions.

H. Zeichhardt, H. Fechner, S. Weger, 2011, Virology.

Complication Rate of Right Ventricular Endomyocardial Biopsy via the Femoral Approach: A Retrospective and Prospective Study Analyzing 3048 Diagnostic Procedures Over an 11-Year Period

W. Hoffmann, C. Tschöpe, B. Witzenbichler, 2008, Circulation.

Sarcoplasmic Reticulum Proteins as Potential Targets for Gene Therapy of Heart Failure

H. Fechner, K. Bezstarosti, W. Poller, 2003 .

Regulation of human factor IX expression using doxycycline-inducible gene expression system

Xiaomin Wang, H. Fechner, J. Oldenburg, 2003, Thrombosis and Haemostasis.

Deadly emotional argument: Sudden cardiac death in catecholaminergic polymorphic ventricular tachycardia (CPVT)

M. Abraham, M. Scheinman, W. Poller, 2022, International journal of cardiology. Heart & vasculature.

Cardiac fibroblasts support cardiac inflammation in heart failure

S. Blankenberg, L. Maier, C. Tschöpe, 2014, Basic Research in Cardiology.

Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies

R. Hetzer, H. Volk, H. Lehmkuhl, 2008, BMC Molecular Biology.

Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.

H. Zeichhardt, H. Kroemer, K. Klingel, 2013, Journal of the American College of Cardiology.

Protease-Activated Receptor-2 Regulates the Innate Immune Response to Viral Infection in a Coxsackievirus B 3 – Induced Myocarditis

H. Zeichhardt, H. Kroemer, K. Klingel, 2022 .

Cardiovascular Involvement in Chronic Hepatitis C Virus Infections – Insight from Novel Antiviral Therapies

U. Bavendiek, U. Landmesser, C. Skurk, 2018, Journal of clinical and translational hepatology.

High incidence of cardiac dysfunction and response to antiviral treatment in patients with chronic hepatitis C virus infection

M. Muche, U. Landmesser, C. Skurk, 2017, Clinical Research in Cardiology.

Interferon- (cid:1) Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction

H. Schultheiss, P. Schwimmbeck, W. Poller, 2003 .

Interferon- (cid:1) Treatment Eliminates Cardiotropic Viruses and Improves Left Ventricular Function in Patients With Myocardial Persistence of Viral Genomes and Left Ventricular Dysfunction

H. Schultheiss, P. Schwimmbeck, W. Poller, 2022 .

Procoagulant Soluble Tissue Factor Is Released From Endothelial Cells in Response to Inflammatory Cytokines

H. Schultheiss, U. Rauch, W. Poller, 2005, Circulation research.

Detailed stratified GWAS analysis for severe COVID-19 in four European populations

Francisco J. Medrano, S. Brunak, V. Moreno, 2022, Human molecular genetics.

Description of a local cardiac adiponectin system and its deregulation in dilated cardiomyopathy.

H. Fechner, C. Skurk, L. Suckau, 2006, European heart journal.

Adiponectin modulates NK‐cell function

H. Volk, C. Scheibenbogen, C. Skurk, 2013, European journal of immunology.

Adiponectin protects against Toll-like receptor 4-mediated cardiac inflammation and injury.

U. Eriksson, C. Scheibenbogen, B. Rauch, 2013, Cardiovascular research.

Adiponectin is a negative regulator of antigen‐activated T cells

H. Volk, Robert Kudernatsch, C. Scheibenbogen, 2011, European journal of immunology.

Adiponectin attenuates profibrotic extracellular matrix remodeling following cardiac injury by up‐regulating matrix metalloproteinase 9 expression in mice

U. Landmesser, C. Skurk, H. Schultheiss, 2017, Physiological reports.

Adiponectin expression in patients with inflammatory cardiomyopathy indicates favourable outcome and inflammation control.

U. Eriksson, C. Scheibenbogen, C. Skurk, 2011, European heart journal.

Autoimmunological features in inflammatory cardiomyopathy

A. Dörner, H. Schultheiss, W. Poller, 2007, Clinical Research in Cardiology.

SERCA2 and ANF Promoter-Activity Studies in Hypertrophic Cardiomyocytes Using Liposome-, Gene Gun-, and Adenovirus-Mediated Gene Transfer

K. Bezstarosti, W. Poller, J. Lamers, 2000 .

Long-term outcome of patients with virus-negative chronic myocarditis or inflammatory cardiomyopathy after immunosuppressive therapy

B. Pieske, C. Tschöpe, D. Westermann, 2016, Clinical Research in Cardiology.

High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults With “Idiopathic” Left Ventricular Dysfunction

R. Kandolf, T. Bock, H. Schultheiss, 2005, Circulation.

Immunomodulatory treatment strategies in inflammatory cardiomyopathy: current status and future perspectives

H. Schultheiss, W. Poller, M. Noutsias, 2004, Expert review of cardiovascular therapy.

Interferon-β Suppresses Transcriptionally Active Parvovirus B19 Infection in Viral Cardiomyopathy: A Subgroup Analysis of the BICC-Trial

H. Schultheiss, G. Aleshcheva, C. Bock, 2022, Viruses.

High Perforin‐Positive Cardiac Cell Infiltration and Male Sex Predict Adverse Long‐Term Mortality in Patients With Inflammatory Cardiomyopathy

B. Pieske, D. Westermann, A. Stroux, 2017, Journal of the American Heart Association.

Familial Recurrent Myocarditis Triggered by Exercise in Patients With a Truncating Variant of the Desmoplakin Gene

K. Klingel, U. Landmesser, L. Monserrat, 2020, Journal of the American Heart Association.

Long noncoding RNA NEAT1 modulates immune cell functions and is suppressed in early onset myocardial infarction patients.

S. Blankenberg, S. Weiss, D. Börnigen, 2019, Cardiovascular research.

Nicotinamide phosphoribosyltransferase/pre-B-cell colony enhancing factor/visfatin plasma levels and clinical outcome in patients with dilated cardiomyopathy.

C. Skurk, H. Schultheiss, U. Rauch, 2015, Journal of cardiac failure.

High leptin and resistin expression in chronic heart failure: adverse outcome in patients with dilated and inflammatory cardiomyopathy

C. Scheibenbogen, C. Skurk, H. Schultheiss, 2012, European journal of heart failure.

Chromosomally integrated human herpesvirus 6 in heart failure: prevalence and treatment

B. Kaufer, G. Krueger, H. Schultheiss, 2015, European journal of heart failure.

Interferon-Beta improves survival in enterovirus-associated cardiomyopathy.

H. Schultheiss, W. Poller, D. Lassner, 2012, Journal of the American College of Cardiology.

Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction.

H. Schultheiss, P. Schwimmbeck, W. Poller, 2003, Circulation.

Induction of Coxsackievirus-Adenovirus–Receptor Expression During Myocardial Tissue Formation and Remodeling: Identification of a Cell-to-Cell Contact–Dependent Regulatory Mechanism

Xiaomin Wang, K. Hinze, H. Fechner, 2003, Circulation.

CAR-diology—a virus receptor in the healthy and diseased heart

H. Schultheiss, M. Gotthardt, R. Fischer, 2009, Journal of Molecular Medicine.

Human coxsackie-adenovirus receptor is colocalized with integrins alpha(v)beta(3) and alpha(v)beta(5) on the cardiomyocyte sarcolemma and upregulated in dilated cardiomyopathy: implications for cardiotropic viral infections.

R. Hetzer, M. Yacoub, A. Houtsmuller, 2001, Circulation.

Matricellular Signaling Molecule CCN1 Attenuates Experimental Autoimmune Myocarditis by Acting as a Novel Immune Cell Migration Modulator

U. Eriksson, S. Heymans, Xiaomin Wang, 2010, Circulation.

Virome Sequencing in Patients With Myocarditis

Paul J. Hanson, B. McManus, T. Lüscher, 2020, Circulation. Heart failure.

CCN1: a novel inflammation-regulated biphasic immune cell migration modulator

C. Meisel, H. Volk, Robert Kudernatsch, 2012, Cellular and Molecular Life Sciences.

Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure

H. Fechner, R. Hajjar, H. Schultheiss, 2010, Cardiovascular research.

Human Coxsackie-Adenovirus Receptor Is Colocalized With Integrins αvβ3 and αvβ5 on the Cardiomyocyte Sarcolemma and Upregulated in Dilated Cardiomyopathy Implications for Cardiotropic Viral Infections

R. Hetzer, M. Yacoub, Xiaomin Wang, 2001 .

Collagen degradation in a murine myocarditis model: relevance of matrix metalloproteinase in association with inflammatory induction.

L. Husmann, S. Leschka, H. Zeichhardt, 2002, Cardiovascular research.

Elevated NT-ProBNP levels in patients with increased left ventricular filling pressure during exercise despite preserved systolic function.

T. Walther, C. Tschöpe, D. Westermann, 2005, Journal of cardiac failure.

Effects of the Cdc2-like kinase-family and DNA topoisomerase I on the alternative splicing of eNOS in TNF-α-stimulated human endothelial cells

H. Schultheiss, A. Eisenreich, U. Rauch, 2008, Biological chemistry.

Hematopoietic Deficiency of the Long Noncoding RNA MALAT1 Promotes Atherosclerosis and Plaque Inflammation

C. Weber, A. Zeiher, S. Dimmeler, 2019, Circulation.

CardiomyopathyTRIF Is a Critical Survival Factor in Viral

S. Felix, A. Dörner, C. Tschöpe, 2011 .

Inflammation and extracellular matrix protein metabolism: two sides of myocardial remodelling

C. Tschöpe, H. Schultheiss, W. Poller, 2002 .

Systemic overexpression of matricellular protein CCN1 exacerbates obliterative bronchiolitis in mouse tracheal allografts

Xiaomin Wang, A. Raissadati, S. Syrjälä, 2015, Transplant international : official journal of the European Society for Organ Transplantation.

Acute Myocarditis Associated With Desmosomal Gene Variants.

A. Keren, L. Cooper, A. Mazzanti, 2022, JACC. Heart failure.

, Dirk Adults With ' ' Idiopathic ' ' Left Ventricular Dysfunction High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of

R. Kandolf, T. Bock, H. Schultheiss, 2005 .

Missense Variant E1295K of Sodium Channel SCN5A Associated With Recurrent Ventricular Fibrillation and Myocardial Inflammation

J. Haas, B. Meder, C. Skurk, 2022, JACC. Case reports.

Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis.

L. Husmann, S. Leschka, H. Zeichhardt, 2007, European journal of pharmacology.

Adenovirus-mediated overexpression and stimulation of the human angiotensin II type 2 receptor in porcine cardiac fibroblasts does not modulate proliferation, collagen I mRNA expression and ERK1/ERK2 activity, but inhibits protein tyrosine phosphatases

E. Fleck, V. Regitz-Zagrosek, M. Gräfe, 2001, Journal of Molecular Medicine.

A novel Troponin I mutation associated with severe restrictive cardiomyopathy—a case report of a 27-year-old woman with fatigue

U. Landmesser, L. Monserrat, W. Poller, 2022, European heart journal. Case reports.

Vaccine protection against lethal homologous and heterologous challenge using recombinant AAV vectors expressing codon-optimized genes from pandemic swine origin influenza virus (SOIV).

R. Kurth, H. Fechner, O. Planz, 2011, Vaccine.

Parvovirus B 19 Infection Mimicking Acute Myocardial Infarction

K. Klingel, R. Kandolf, T. Bock, 2003 .

Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy.

H. Schultheiss, W. Poller, M. Noutsias, 2003, Heart failure monitor.

Multimodality Imaging Reveals Divergent Responses of Left and Right Heart to Treatment in Cardiac Amyloidosis

M. Taupitz, U. Landmesser, C. Skurk, 2019, JACC. Case reports.

Parvovirus B19 Infection Mimicking Acute Myocardial Infarction

K. Klingel, R. Kandolf, T. Bock, 2003, Circulation.

The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements.

Dirk Westermann, C. Tschöpe, D. Westermann, 2005, European heart journal.

tRNA-like Transcripts from the NEAT1-MALAT1 Genomic Region Critically Influence Human Innate Immunity and Macrophage Functions

U. Völker, A. Tzvetkova, Shinichi Nakagawa, 2022, Cells.

Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

S. Blankenberg, S. Heymans, C. Weber, 2018, European heart journal.

New susceptibility loci for severe COVID-19 by detailed GWAS analysis in European populations

M. Nöthen, S. Brunak, V. Moreno, 2021, medRxiv.

Innate Immunity in Cardiovascular Diseases—Identification of Novel Molecular Players and Targets

A. Tzvetkova, C. Skurk, A. Kuss, 2023, Journal of clinical medicine.

Tissue factor expression pattern in human non-small cell lung cancer tissues indicate increased blood thrombogenicity and tumor metastasis.

I. Fichtner, H. Schultheiss, S. Coupland, 2008, Oncology reports.

The molecular basis of cardiotropic viral infections

H. Fechner, H. Schultheiss, W. Poller, 2002 .

Pharmacological and Biological Antiviral Therapeutics for Cardiac Coxsackievirus Infections

S. Pinkert, H. Fechner, J. Kurreck, 2011, Molecules.

Combination of soluble coxsackievirus-adenovirus receptor and anti-coxsackievirus siRNAs exerts synergistic antiviral activity against coxsackievirus B3.

V. Erdmann, H. Zeichhardt, S. Pinkert, 2009, Antiviral research.

Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction

P. Steendijk, C. Tschöpe, C. Skurk, 2011, Circulation. Heart failure.

Cardiovascular RNA interference therapy: the broadening tool and target spectrum.

C. Skurk, W. Poller, M. Gast, 2013, Circulation research.

Long noncoding RNA MALAT1-derived mascRNA is involved in cardiovascular innate immunity.

B. Schroen, S. Heymans, Xiaomin Wang, 2016, Journal of molecular cell biology.

Mapping the human genetic architecture of COVID-19

Mattia G. Bergomi, Christopher M. DeBoever, Matthew A. Wiles, 2021, Nature.

The Cardiac Mechanical Stretch Sensor Machinery Involves a Z Disc Complex that Is Defective in a Subset of Human Dilated Cardiomyopathy

Masahiko Hoshijima, Andrew D. McCulloch, Nicholas J. Schork, 2002, Cell.

Cardiac-targeted RNA interference mediated by an AAV9 vector improves cardiac function in coxsackievirus B3 cardiomyopathy

V. Erdmann, Xiaomin Wang, H. Zeichhardt, 2008, Journal of Molecular Medicine.

Viral and nonviral factors causing nonspecific replication of tumor- and tissue-specific promoter-dependent oncolytic adenoviruses.

Xiaomin Wang, H. Fechner, J. Eberle, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01

Xiaomin Wang, M. Holtgrewe, D. Beule, 2021, EClinicalMedicine.

An improved Tet-On regulatable FasL-adenovirus vector system for lung cancer therapy

I. Petersen, Xiaomin Wang, H. Fechner, 2006, Journal of Molecular Medicine.

Coronary vasospasm–induced acute diastolic dysfunction in a patient with Raynaud’s phenomenon

P. Steendijk, C. Tschöpe, D. Westermann, 2006, Clinical Research in Cardiology.

Identification of novel antigens contributing to autoimmunity in cardiovascular diseases.

H. Katus, E. Giannitsis, C. Weiss, 2016, Clinical immunology.

Viral Persistence in the Myocardium Is Associated With Progressive Cardiac Dysfunction

H. Schultheiss, W. Poller, M. Noutsias, 2005, Circulation.

Utility of Doppler Echocardiography and Tissue Doppler Imaging in the Estimation of Diastolic Function in Heart Failure With Normal Ejection Fraction: A Comparative Doppler-Conductance Catheterization Study

Wolfgang Hoffmann, Dirk Westermann, Paul Steendijk, 2007, Circulation.

An isoform shift in the cardiac adenine nucleotide translocase expression alters the kinetic properties of the carrier in dilated cardiomyopathy

R. Hetzer, A. Dörner, H. Schultheiss, 2006, European journal of heart failure.

Prevention of Cardiac Dysfunction in Acute Coxsackievirus B3 Cardiomyopathy by Inducible Expression of a Soluble Coxsackievirus-Adenovirus Receptor

Xiaomin Wang, W. Hoffmann, H. Zeichhardt, 2009, Circulation.

Effect of ionizing radiation on cellular procoagulability and co-ordinated gene alterations.

D. Lenze, M. Hummel, H. Schultheiss, 2007, Haematologica.

Cardiac sarcoidosis presenting with complex conduction abnormalities as the first manifestation of widespread systemic sarcoidosis: a case report

C. Skurk, W. Poller, B. Siegmund, 2023, European heart journal. Case reports.

Differential Cardiac MicroRNA Expression Predicts the Clinical Course in Human Enterovirus Cardiomyopathy

Christine S. Siegismund, Xiaomin Wang, C. Scheibenbogen, 2015, Circulation. Heart failure.

Cardiovascular consequences of viral infections: from COVID to other viral diseases

H. Schultheiss, C. Bock, W. Poller, 2021, Cardiovascular research.

Molecular genetic and expression analysis of alpha-tocopherol transfer protein mRNA in German shepherd dogs with degenerative myelopathy.

A. C. Looman, Xiaomin Wang, H. Fechner, 2003, Berliner und Munchener tierarztliche Wochenschrift.

Protein modification with ISG15 blocks coxsackievirus pathology by antiviral and metabolic reprogramming

K. Knobeloch, K. Klingel, H. Fechner, 2020, Science Advances.

Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts.

Xiaomin Wang, C. Scheibenbogen, K. Klingel, 2014, Journal of molecular and cellular cardiology.

Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.

R. Klopfleisch, H. Zeichhardt, S. Pinkert, 2015, The Journal of infectious diseases.

Adenovirus-mediated regulatable Expression of human Factor IX in vitro and in vivo

Xiaomin Wang, H. Fechner, J. Oldenburg, 2003 .

Coxsackievirus B3 and adenovirus infections of cardiac cells are efficiently inhibited by vector-mediated RNA interference targeting their common receptor

H. Zeichhardt, S. Pinkert, A. Dörner, 2007, Gene Therapy.

Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions.

Xiaomin Wang, S. Pinkert, H. Fechner, 2010, Antiviral research.

RNA Interference and MicroRNA Modulation for the Treatment of Cardiac Disorders

S. Pinkert, H. Fechner, L. Suckau, 2008, RNA Technologies in Cardiovascular Medicine and Research.

TRIF Is a Critical Survival Factor in Viral Cardiomyopathy

S. Felix, A. Dörner, C. Tschöpe, 2011, The Journal of Immunology.

Endogenous migration modulators as parent compounds for the development of novel cardiovascular and anti‐inflammatory drugs

C. Scheibenbogen, C. Skurk, W. Poller, 2012, British journal of pharmacology.

Application of Magnetocardiography to Screen for Inflammatory Cardiomyopathy and Monitor Treatment Response.

C. Skurk, W. Poller, B. Heidecker, 2023, Journal of the American Heart Association.

Long-Term Cardiac-Targeted RNA Interference for the Treatment of Heart Failure Restores Cardiac Function and Reduces Pathological Hypertrophy

V. Erdmann, H. Ly, Xiaomin Wang, 2009, Circulation.

Role of the phosphatidylinositol 3-kinase/protein kinase B pathway in regulating alternative splicing of tissue factor mRNA in human endothelial cells.

H. Schultheiss, A. Eisenreich, U. Rauch, 2009, Circulation journal : official journal of the Japanese Circulation Society.

Cdc2-Like Kinases and DNA Topoisomerase I Regulate Alternative Splicing of Tissue Factor in Human Endothelial Cells

A. Pries, H. Schultheiss, A. Zakrzewicz, 2009, Circulation research.

Regulation of Human Endothelial Cell Focal Adhesion Sites and Migration by cGMP-dependent Protein Kinase I*

U. Walter, S. Lohmann, W. Poller, 2000, The Journal of Biological Chemistry.

Molecular characterisation of the defective α1-antitrypsin alleles PI Mwürzburg (Pro369Ser), Mheerlen (Pro369Leu), and Q0lisbon (Thr68lle)

H. Fechner, A. Haack, W. Poller, 1999, European Journal of Human Genetics.

RNA Technologies in Cardiovascular Medicine and Research

J. Barciszewski, V. Erdmann, W. Poller, 2008 .

CCN1: a novel inflammation-regulated biphasic immune cell migration modulator

C. Meisel, H. Volk, Robert Kudernatsch, 2012, Cellular and Molecular Life Sciences.

New Therapeutics Targets in Chronic Viral Cardiomyopathy

H. Fechner, H. Schultheiss, W. Poller, 2006, Ernst Schering Research Foundation workshop.

A bidirectional Tet-dependent promotor construct regulating the expression of E1A for tight control of oncolytic adenovirus replication.

Xiaomin Wang, S. Pinkert, H. Fechner, 2007, Journal of biotechnology.

A Novel Artificial MicroRNA Expressing AAV Vector for Phospholamban Silencing in Cardiomyocytes Improves Ca2+ Uptake into the Sarcoplasmic Reticulum

U. Völker, S. Pinkert, H. Fechner, 2014, PloS one.

Development of novel cardiovascular therapeutics from small regulatory RNA molecules--an outline of key requirements.

H. Fechner, W. Poller, 2010, Current pharmaceutical design.

cGMP Stimulation of Cystic Fibrosis Transmembrane Conductance Regulator Cl− Channels Co-expressed with cGMP-dependent Protein Kinase Type II but Not Type Iβ*

S. Lohmann, T. Jarchau, B. Scholte, 1997, The Journal of Biological Chemistry.

Alterations in myocardial tissue factor expression and cellular localization in dilated cardiomyopathy.

R. Hetzer, A. Dörner, M. Hummel, 2005, Journal of the American College of Cardiology.

Release of active and depot GDF-5 after adenovirus-mediated overexpression stimulates rabbit and human intervertebral disc cells

W. Richter, M. Kroeber, W. Poller, 2004, Journal of Molecular Medicine.

Genomic expression profiling of human inflammatory cardiomyopathy (DCMi) suggests novel therapeutic targets

H. Fechner, C. Tschöpe, C. Skurk, 2006, Journal of Molecular Medicine.

The molecular basis of α1-antichymotrypsin deficiency in a heterozygote with liver and lung disease

W. Poller, K. Olek, J. Carlson, 1993 .

Mapping the human genetic architecture of COVID-19

Mattia G. Bergomi, Christopher M. DeBoever, Matthew A. Wiles, 2021, Nature.

Cardiac-targeted delivery of regulatory RNA molecules and genes for the treatment of heart failure

H. Fechner, R. Hajjar, H. Schultheiss, 2010, Cardiovascular research.

Nucleic acid-based modulation of cardiac gene expression for the treatment of cardiac diseases

V. Erdmann, H. Fechner, J. Kurreck, 2004, Zeitschrift für Kardiologie.

Severe heart failure in the setting of inflammatory cardiomyopathy with likely pathogenic titin variant

K. Klingel, U. Landmesser, S. Klaassen, 2022, International journal of cardiology. Heart & vasculature.

Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio.

H P Schultheiss, W. Poller, H. Schultheiss, 1999, Circulation.

Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy

W. Poller, H. Schultheiss, W. Poller, 2008, Journal of medical virology.

Correction: A Novel Artificial MicroRNA Expressing AAV Vector for Phospholamban Silencing in Cardiomyocytes Improves Ca2+ Uptake into the Sarcoplasmic Reticulum

U. Völker, S. Pinkert, H. Fechner, 2014, PLoS ONE.

A second update on mapping the human genetic architecture of COVID-19

M. A. Hakim Newton, Jack D. Sanders, Jonathan H. Morgan, 2022, Nature.

Silencing Genes in the Heart.

H. Fechner, J. Kurreck, R. Vetter, 2017, Methods in molecular biology.

A distinct subgroup of cardiomyopathy patients characterized by transcriptionally active cardiotropic erythrovirus and altered cardiac gene expression

A. Dörner, C. Skurk, W. Poller, 2013, Basic Research in Cardiology.

Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction

P. Steendijk, C. Tschöpe, C. Skurk, 2011, Circulation. Heart failure.

Reduced Degradation of the Chemokine MCP-3 by Matrix Metalloproteinase-2 Exacerbates Myocardial Inflammation in Experimental Viral Cardiomyopathy

U. Völker, K. Klingel, C. Tschöpe, 2011, Circulation.

Adiponectin protects against Toll-like receptor 4-mediated cardiac inflammation and injury.

U. Eriksson, C. Scheibenbogen, B. Rauch, 2013, Cardiovascular research.

Kardiomyopathien

W. Poller, D. Lassner, U. Kühl, 2005, Der Internist.

Long-Term Cardiac-Targeted RNA Interference for the Treatment of Heart Failure Restores Cardiac Function and Reduces Pathological Hypertrophy

V. Erdmann, H. Ly, Xiaomin Wang, 2009, Circulation.

Alternatively spliced tissue factor and full-length tissue factor protect cardiomyocytes against TNF-α-induced apoptosis.

A. Eisenreich, U. Rauch, W. Poller, 2012, Journal of molecular and cellular cardiology.

Impact of the Gut Microbiota on Atorvastatin Mediated Effects on Blood Lipids

U. Landmesser, D. Leistner, M. Heimesaat, 2020, Journal of clinical medicine.

FOXO3A acts as immune response modulator in human virus-negative inflammatory cardiomyopathy

C. Scheibenbogen, C. Skurk, H. Schultheiss, 2023, Heart.

Improved diagnosis of idiopathic giant cell myocarditis and cardiac sarcoidosis by myocardial gene expression profiling.

Christine S. Siegismund, W. Poller, F. Escher, 2014, European heart journal.

Interferon-Beta improves survival in enterovirus-associated cardiomyopathy.

H. Schultheiss, W. Poller, D. Lassner, 2012, Journal of the American College of Cardiology.

Adiponectin expression in patients with inflammatory cardiomyopathy indicates favourable outcome and inflammation control.

U. Eriksson, C. Scheibenbogen, C. Skurk, 2011, European heart journal.

Genome–environment interactions in the molecular pathogenesis of dilated cardiomyopathy

H. Fechner, W. Poller, H. Schultheiss, 2005, Journal of Molecular Medicine.

Regulation of cardiomyocyte full‐length tissue factor expression and microparticle release under inflammatory conditions in vitro

W. Poller, A. Eisenreich, U. Rauch, 2009, Journal of thrombosis and haemostasis : JTH.

Circulating exosomal microRNAs predict functional recovery after MitraClip repair of severe mitral regurgitation.

U. Landmesser, C. Skurk, P. Dohmen, 2016, International journal of cardiology.

Detailed stratified GWAS analysis for severe COVID-19 in four European populations

M. Buti, J. Barretina, P. Rosenstiel, 2022, Human Molecular Genetics.

Abstract 2563: Description of a Local Cardiac Adiponectin System and its Deregulation in Dilated Cardiomyopathy

H. Fechner, C. Skurk, L. Suckau, 2006 .

Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses

C. Scheibenbogen, S. Pinkert, K. Klingel, 2014, Basic Research in Cardiology.